ACTIVE

ACLOT PHARMA

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result47 k €+799,0 %over 1 year
Gross margin361,8 k €+19,1 %over 1 year
Equity126,8 k €+5,8 %over 1 year
Workforce2,4 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

ACLOT PHARMA is a Private limited company incorporated in 1995. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Nivelles. It employs on average 2,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0456.857.330
Incorporation
20/12/1995
Legal form
Private limited company
Registered office
Rue du Paradis 101
1400 Nivelles · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Average workforce
2,4 ETP
Joint committees (1)
  • 313
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20242023202220212020
Income statement
Gross margin361,8 k €303,7 k €313,8 k €258,7 k €153,8 k €
EBITDA162,8 k €109,6 k €122,3 k €70 k €18,7 k €
Operating result58,8 k €3,5 k €35,6 k €6 k €5,1 k €
Net result47 k €-6,7 k €25,4 k €-3,6 k €-239,9 €
Balance sheet
Equity126,8 k €119,8 k €126,5 k €101,1 k €104,7 k €
Total assets1,4 M €1,4 M €1,4 M €1,2 M €1,2 M €
Cash171,1 k €98,6 k €86,5 k €181,7 k €56,5 k €
Debts1,3 M €1,3 M €1,3 M €1,1 M €1,1 M €
Other
Workforce2,4 ETP2,4 ETP–––

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

4 active · 10 ended

Active mandates

EGUIMAX INVEST

Director · 0667.584.187

Represented by PHILIPPE DEHAYE

Active
GFCS INVEST

Director · 0667.583.296

Represented by ALEXANDRE DEHAYE

Active
Nadine Demeulemeester

Director

Active
PHILIPPE DEHAYE

Director

Active

Ended mandates

GHISLAINE MEUREE

Manager · since 20 décembre 1995

Ended
EGUIMAX INVEST

Director · 0667.584.187

Represented by Philippe Dehaye

Ended
EGUIMAX INVEST

Manager · 0667.584.187

Represented by Anne DEJARDIN

Ended
EGUIMAX INVEST

Manager · 0667.584.187

Represented by Anne DEJARDIN

Ended

Other companies at this address

Rue du Paradis 101 1400 Nivelles
CompanyCBE no.
Association des copropriétaires de la résidence sise rue du Paradis, 101 et chaussée de Hal, 34 à 1400 Nivelles● Active
0754.958.324

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date04/07/202530/08/202428/07/202327/07/202231/08/202128/10/2020
General meeting21/05/202515/05/202417/05/202311/05/202219/05/202120/05/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202421/05/202504/07/2025FrenchPDF
Abridged model31/12/202315/05/202430/08/2024FrenchPDF
Micro model31/12/202217/05/202328/07/2023FrenchPDF
Micro model31/12/202111/05/202227/07/2022FrenchPDF
Micro model31/12/202019/05/202131/08/2021FrenchPDF
Micro model31/12/201920/05/202028/10/2020FrenchPDF
Abridged model31/12/201815/05/201930/07/2019FrenchPDF
Abridged model31/12/201716/05/201831/08/2018FrenchPDF
Abridged model31/12/201617/05/201729/06/2017FrenchPDF
Abridged model31/12/201512/05/201626/09/2016FrenchPDF
Abridged model31/12/201414/05/201523/09/2015FrenchPDF
Abridged model31/12/201315/05/201425/09/2014FrenchPDF
Abridged model31/12/201216/05/201329/09/2013FrenchPDF
Abridged model31/12/201117/05/201219/08/2012FrenchPDF
Abridged model31/12/201018/05/201115/06/2011FrenchPDF
Abridged model31/12/200919/05/201002/06/2010FrenchPDF
Abridged model31/12/200820/05/200919/08/2009FrenchPDF
Abridged model31/12/200721/05/200814/08/2008FrenchPDF
Abridged model31/12/200616/05/200728/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

4 active · 10 ended

Active mandates

EGUIMAX INVEST

Director · 0667.584.187

Represented by PHILIPPE DEHAYE

Active
GFCS INVEST

Director · 0667.583.296

Represented by ALEXANDRE DEHAYE

Active
Nadine Demeulemeester

Director

Active
PHILIPPE DEHAYE

Director

Active

Ended mandates

GHISLAINE MEUREE

Manager · since 20 décembre 1995

Ended
EGUIMAX INVEST

Director · 0667.584.187

Represented by Philippe Dehaye

Ended
EGUIMAX INVEST

Manager · 0667.584.187

Represented by Anne DEJARDIN

Ended
EGUIMAX INVEST

Manager · 0667.584.187

Represented by Anne DEJARDIN

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates01/10/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office30/12/2020
    SIEGE SOCIAL
    PDF
  • Mandates15/09/2020
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates15/02/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates07/09/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares01/03/2004
    CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202447 k €↑
  2. 2023
    Annual accounts 2023-6,7 k €↓
  3. 2022
    Annual accounts 202225,4 k €↑
  4. 2021
    Annual accounts 2021-3,6 k €↓
  5. 2020
    Annual accounts 2020-239,9 €↑
  6. 2019
    Annual accounts 2019-3,4 k €↓
  7. 2019
    Name changeACLOT PHARMA
  8. 2018
    Annual accounts 20188,5 k €↑
  9. 2017
    Annual accounts 2017-25,9 k €↓
  10. 2016
    Annual accounts 2016-6,5 k €↓
  11. 2015
    Annual accounts 20154,5 k €↓
  12. 2014
    Annual accounts 20145,9 k €↓
  13. 2013
    Annual accounts 20139,8 k €↑
  14. 2012
    Annual accounts 20129,8 k €↓
  15. 2011
    Annual accounts 201110,2 k €↑
  16. 2010
    Annual accounts 20106,7 k €↓
  17. 2009
    Annual accounts 200916,1 k €↑
  18. 2008
    Annual accounts 20082,5 k €↑
  19. 2007
    Annual accounts 20071,3 k €↓
  20. 2006
    Annual accounts 200615,8 k €
  21. 2006
    Name changePHARMACIE G. MEUREE
  22. 20/12/1995
    IncorporationPrivate limited company